Neurim Pharmaceuticals was unsuccessful in overcoming the examiner’s repeated objections to its New Zealand patent application, but the application will be accepted subject to generous amendments directed by Assistant Commissioner Luiten....
3 ways to spot the signs of burnout
27 Jul 2022
0
So often I am asked, “How can I recognise when someone I work with is feeling...
READ MORE
Soda-ceptive – did a straw man suppress the true patent opponent’s identity from foaming over?
14 Jul 2022
0
Steven Borovec v Suntory Holdings Limited [2022] APO 33
Background
The use of Stevia rebauidiana Bertoni to sweeten...
READ MORE
The New Zealand Intellectual Property Office is the latest authority to reject Stephen Thaler’s efforts to...
READ MORE
Charting IP roadmaps for investments into Africa
07 Jun 2022
0
Why invest in Africa?
Africa is the world’s fastest growing continent and six of its countries are...
READ MORE
Hashtag – a word, phrase, or sentence prefaced by the hash symbol ‘#’ – is a...
READ MORE
DABUS has crashed – no natural person found on board
16 May 2022
0
DABUS is an alleged artificial intelligence, and the Artificial Inventor Project have been testing the bounds...
READ MORE
On appeal, the Full Court of the Federal Court of Australia (Middleton, Nicholas, and Burley JJ)...
READ MORE
Australian Registered Designs Law Reform – introduction of a ‘grace period’ and other changes
27 Apr 2022
0
The current Australian designs system has been in force since the commencement of the Designs Act...
READ MORE
BECOME A MEMBER OF FICPI
FICPI is unique, being the only international NGO whose membership consists exclusively of IP attorneys in private practice. FICPI thus represents an important constituency within the international IP system.